ISHL13 Abstracts

Limited stages

T049: Factors driving treatment intensity in the whole cohort of patients with early-stage favorable (I-IIA), nonbulky Hodgkin Lymphoma enrolled in the RAFTING trial (NCT 04866654).
Authors:
- Jan Maciej Zaucha
- Marco Picardi
- Kateryna Filonenko
- Manuel Gotti
- Javier Nunez
- Andrea Rossi
- Eva Domingo-Domènech
- Agnieszka Giza
- Roberto Sorasio
- Andrea Visentin
- Mariana Bastos
- Ewa Paszkiewicz-Kozik
- Ramon Garcia-Sanz
- Caterina Patti
- Stephane Chauvie
- Fabrizio Bergesio
- Luca Guerra
- Anna Sureda
- Andrea Gallamini
Abstract Talk in “Limited Stages”
T050: Nodular lymphocyte predominant Hodgkin lymphoma in the Nordic countries – characteristics, treatment and survival
Authors:
- Kossi D Abalo
- Katrin Bamdeg-Hvolbek
- Frida Ekeblad
- Ilja Kalashnikov
- Johan Linderoth
- Dennis Lund Hansen
- Gunilla Enblad
- Urban Jerlstrom
- Christina Goldkuhl
- Taina Reunamo
- Marjukka Pollari
- Martin Hutchings
- Peter Kamper
- Rasmus Bo Dahl-Sørensen
- Ingemar Lagerlöf
- Ann-Sofie Johansson
- Lotta Hansson
- Daniel Molin
- Sirpa M. Leppä
- Tarec Christoffer El-Galaly
- Ingrid Glimelius
View full abstract at Hemasphere…
Abstract Talk in “Limited Stages”
T051: Serum TARC Dynamics Correlate with Clinical Response and Metabolic Tumor Volume During Anti-PD1-Based First-Line HL Treatment in The GHSG Phase II NIVAHL Trial
Authors:
- Wouter J. Plattel
- Sophie Teesink
- Lydia Visser
- Conrad-Amadeus Voltin
- Helen Kaul
- Hans A. Schlösser
- Bart-Jan Kroesen
- Carsten Kobe
- Peter Borchmann
- Arja Diepstra
- Paul J. Bröckelmann
View full abstract at Hemasphere…
Abstract Talk in “Limited Stages”
P052: AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma
Authors:
- Jennifer Seelisch
- Boyu Hu
- Lindsay A. Renfro
- Frank G. Keller
- Adam DuVall
- Tara O. Henderson
- Yue Wu
- Steve Yoon-Ho Cho
- Bradford S. Hoppe
- Sarah Milgrom
- Lisa Giulino Roth
- Natalie S. Grover
- Ann S. LaCasce
- Justine M. Kahn
- Song Yao
- Susan K. Parsons
- Niloufer Khan
- Raymond Mailhot Vega
- Pamela S. Hinds
- Pamela B. Allen
- Andrew M. Evens
- Heiko Schoder
- Sharon M. Castellino
- Kara M. Kelly
View full abstract at Hemasphere…
P053: Development and validation of the Early stage (ES) classic Hodgkin Lymphoma (cHL) International Prognostication Index (E-HIPI): an individualized prediction model for progression-free survival (PFS) utilizing objective and continous variables
Authors:
- Angie Mae Rodday
- John Radford
- Matthew Maurer
- Jenica Upshaw
- Nicholas Counsell
- Sara Rossetti
- Ranjana H. Advani
- Marc Andre
- Cheryl Chang
- Andrea Gallamini
- Annette Hay
- David Hodgson
- Richard Hoppe
- Martin Hutchings
- Peter Johnson
- Eric Mou
- Stephen Opat
- John M.M. Raemaekers
- Kerry Savage
- Qingyan Xiang
- Susan K. Parsons
- Andrew Evens
View full abstract at Hemasphere…
P054: Individualized Immunotherapy in Early-Stage Unfavorable Hodgkin Lymphoma - The Investigator-Initiated Phase II GHSG INDIE Trial (Trial in Progress)
Authors:
- Paul J. Bröckelmann
- Helen Kaul
- Michael Fuchs
- Carsten Kobe
- Christian Baues
- Wolfram Klapper
- Bastian von Tresckow
- Peter Borchmann
View full abstract at Hemasphere…
P055: King Faisal Specialist Hospital and Research Centre
Authors:
- Reyad Dada
- John Apostolidis
- Refaei Belal Ibrahim
- Asma Ahmed Salem
- Mostafa Ibrahim Mahmoud
- Hafiz Asif Iqbal
- Tarik Boubakra
- Hamza Ghatasheh
- Azahr Nawaz
- Khalid Halahleh
View full abstract at Hemasphere…
P056: Pediatric Infradiaphragmatic Hodgkin’s lymphoma: a unique identity
Authors:
- Asmaa Hamoda
- Nashwa Ezzeldeen
- Emad Moussa
- Madeeha A.T. El Wakeel
- Eman Khorshed
- Maha Mehesen
- amr elnashar
- Sara abdelkareem
- Mohamed Zaghloul
View full abstract at Hemasphere…
P057: Proton therapy for limited stage classical Hodgkin lymphoma patients (PRO-Hodgkin): an interim analysis of clinical outcome.
Authors:
- Christina Goldkuhl
- Anna Bäck
- Gunilla Enblad
- Ingrid Glimelius
- Lotta Hansson
- Urban Jerlström
- Ann-Sofie Johansson
- Jenny Kahlmeter-Brandell
- Johan Linderoth
- Marzia Palma
- Daniel Molin
View full abstract at Hemasphere…
P058: Real-life data on morbidity and cause-specific mortality after combined modality treatment for classical Hodgkin lymphoma 2006-2015.
Authors:
- Ingemar Lagerlöf
- Per Wikman
- Gunilla Enblad
- Christina Goldkuhl
- Marzia Palma
- Helena Fohlin
- Ingrid Glimelius
- Daniel Molin
View full abstract at Hemasphere…
P059: Safe Radiotherapy for Pregnant Women with Hodgkin's Lymphoma: Myth or Reality?
Authors:
- Elżbieta Wojciechowska-Lampka
- Magdalena Rosińska
- Jacek Lampka
- Włodzimierz Osiadacz
- Joanna Tajer
- Agnieszka Kuchcińska
View full abstract at Hemasphere…
P060: Total metabolic tumor volume impairs the successful detection of circulating tumor DNA (ctDNA) in early-stage Hodgin lymphoma patients – the preliminary report from the RAFTING trial.
Authors:
- Marta Bednarek
- Stephane Chauvie
- Maria Pirosa
- Luca Guerra
- Annibale Versari
- Michele Gregianin
- Fabrizio Bergesio
- Katia Pini
- Georgia Alice Galimberti
- Simone Bocchetta
- Matin Salehi
- Adam Wyszomirski
- Alessandro Rambaldi
- Marco Picardi
- Kateryna Filonenko
- Michał Kurlapski
- Anna Sureda
- Davide Rossi
- Andrea Gallamini
- Jan Maciej Zaucha
View full abstract at Hemasphere…
P061: Variation in the delivery of radiotherapy as part of frontline curative treatment for Hodgkin lymphoma across healthcare providers in England
Authors:
- David Jones
- Philip Clarke
- Jane Wolstenholme
- David Cutter
- John Broggio
View full abstract at Hemasphere…

Pediatric and adolescent

T086: EFFICACY and TOLERABILITY in DECOPDAC21 versus COPDAC28 in PEDIATRIC INTERMEDIATE and ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA: INTERIM RESULTS of the EURONET-PHL-C2 RANDOMIZED STUDY
Authors:
- Dieter Körholz
- Maurizio Mascarin
- Judith Landman-Parker
- Thierry Leblanc
- Lars Kurch
- Thomas W. Georgi
- Regine Kluge
- Dietrich Stoevesandt
- Tanja Pelz
- Dirk Vordermark
- Karin Dieckmann
- Stephen Daw
- Ana Fernandez-Teijeiro
- Galia Avrahami
- Leanne Super
- Auke Beishuizen
- Walentyna Balwierz
- Tomasz Klekawka
- Anne Uyttebroeck
- Andishe Attarbaschi
- Michaela Cepelova
- Francesco Ceppi
- Alexander Fosså
- Tim Prestidge
- Annika Englund
- Lisa Lyngsie Hjalgrim
- Wolfram Klapper
- Dirk Hasenclever
- Christine Mauz-Körholz
View full abstract at Hemasphere…
Abstract Talk in “Pediatric and Adolescent Treatment Concepts”
T087: Progression-Free Survival (PFS) with Nivolumab-AVD is superior to Brentuximab Vedotin-AVD with 2-year follow-up of S1826 in Adolescent Advanced Stage (AS) Classic Hodgkin Lymphoma (cHL)
Authors:
- Sharon M. Castellino
- Hongli Li
- Alex F. Herrera
- Angela Punnett
- Michael Le
- Susan K. Parsons
- Frank G. Keller
- Richard Drachtman
- Adam Lamble
- Christopher J. Forlenza
- Andrew Doan
- Sarah Rutherford
- Andrew Evens
- David Hodgson
- Richard F. Little
- Malcom Smith
- Hildy Dillon
- Joo Song
- Sonali Smith
- Jonathan W. Friedberg
- Kara M. Kelly
View full abstract at Hemasphere…
Abstract Talk in “Pediatric and Adolescent Treatment Concepts”
T088: Updated Results from the Phase 2 KEYNOTE-667 Study: Pembrolizumab (pembro) in Children and Young Adults With Low-Risk Classical Hodgkin Lymphoma (cHL) and Slow Early Response (SER) to Front-Line Chemotherapy (chemo)
Authors:
- Lisa Giulino-Roth
- Mario Melgar Toledo
- Frank G. Keller
- Bradford S. Hoppe
- Christopher J. Forlenza
- Sharon M. Castellino
- Maitane Andion Catalan
- Julie Krystal
- Adam Lamble
- Flavio Luisi
- Fabio Molina Morales
- Aarati V. Rao
- Stacy Cooper
- Oscar Gonzalez-Llano
- Luis Juarez Villegas
- Christine Mauz-Körholz
- Juan Shen
- Pallavi Pillai
- Rushdia Yusuf
- Kara M. Kelly
View full abstract at Hemasphere…
Abstract Talk in “Pediatric and Adolescent Treatment Concepts”
P089: An audit of compliance with recommendations for screening and management of Hodkins lymphoma in teenager and young adult population. Results from a baseline audit within the northern health and social care trust.
Authors:
- Esraa Yousif
- Kerrie Sweeney
- Aaron Niblock
View full abstract at Hemasphere…
P090: Brentuximab-Associated Alopecia in Children and Young Adults with Newly Diagnosed Hodgkin Lymphoma
Authors:
- Jonathan D. Bender
- Angela T. Faulhaber
- Robin E. Norris
View full abstract at Hemasphere…
P091: Clinical study of immune-targeting combined with attenuated chemotherapy in the treatment of pediatric Hodgkin lymphoma
Authors:
- Huixia Gao
- Yanlong Duan
View full abstract at Hemasphere…
P092: CNS Involvement in Pediatric Hodgkin Lymphoma: A Retrospective Analysis of AHOD1331, EuroNet-PHL-C1 and EuroNet-PHL-C2 from SEARCH for CAYAHL
Authors:
- Reena Pabari
- Kathleen McCarten
- Jamie E. Flerlage
- Hollie Lai
- Christine Mauz-Körholz
- Karin Dieckmann
- Monica Palese
- Sue C. Kaste
- Sharon M. Castellino
- Kara M. Kelly
- Dietrich Stoevesandt
- Lars Kurch
View full abstract at Hemasphere…
P093: Definition of independent lymph node regions in pediatric HL. An expert consensus by an International Collaboration on Staging Evaluation and Response Criteria Harmonization (SEARCH) for Children, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL)
Authors:
- Dietrich Stoevesandt
- Jonas Steglich
- Lars Kurch
- Jamie E. Flerlage
- Christine Mauz-Körholz
- Dieter Körholz
- Regine Kluge
- Dirk Vordermark
- Bradford S. Hoppe
- Karin Dieckmann
- Claire Gowdy
- Stephan Voss
View full abstract at Hemasphere…
P094: Dose-dense chemotherapy enables elimination of radiotherapy for a majority of patients with low-risk pediatric Hodgkin lymphoma: a report on HOD08 from the Pediatric Hodgkin Consortium
Authors:
- Jamie E. Flerlage
- Angela Feraco
- Yiwang Zhou
- Ying Zheng
- Lia Jiang
- John Lucas
- Alison Friedmann
- Howard Weinstein
- Torunn Yock
- Barry Shulkin
- Sue C. Kaste
- Lianna Marks
- Matthew Ehrhart
- Stephanie Dixon
- Scott Howard
- Pedro de Alarcon
- Sandra Luna-Fineman
- Amy Geddis
- Eric Larsen
- Karen Marcus
- Amy Billett
- Sarah Donaldson
- Melissa Hudson
- Monika Metzger
- Matthew Krasin
- Michael Link
View full abstract at Hemasphere…
P095: Group-Based Trajectories of Health-related Quality of Life (HRQoL) among Patients with High-Risk Pediatric Hodgkin Lymphoma treated on the Children’s Oncology Group (COG) AHOD 1331 Study
Authors:
- AnnaLynn Williams
- Angie Mae Rodday
- Lindsay A. Renfro
- Yue Wu
- Tara O. Henderson
- Frank G. Keller
- Kara Kelly
- Sharon M. Castellino
- Susan K. Parsons
View full abstract at Hemasphere…
P096: International Harmonization Efforts for Pediatric, Adolescent and Young Adult Hodgkin Lymphoma: A Current Report from the SEARCH FOR CAYAHL Group
Authors:
- Jennifer Seelisch
- Kara M. Kelly
- Angela Punnett
- Christine Mauz-Körholz
- Lianna Marks
- Monica Palese
- Reena Pabari
- Karin Dieckmann
- Hollie Lai
- Claire Gowdy
- Jonas Steglich
- Richard Drachtman
- Stephan D Voss
- Bradford S. Hoppe
- Kathleen McCarten
- Lars Kurch
- Auke Beishuizen
- Dietrich Stoevesandt
- Jamie E. Flerlage
View full abstract at Hemasphere…
P097: Is the EVA regimen (etoposide, vinblastine, doxorubicin) safe and effective for treating Hodgkin's lymphoma in pregnant patients?
Authors:
- Elżbieta Wojciechowska-Lampka
- Magdalena Rosińska
- Jacek Lampka
- Zbigniew Nowecki
- Włodzimierz Osiadacz
- Joanna Tajer
- Joanna Romejko-Jarosińska
View full abstract at Hemasphere…
P098: Omitting radiation in young adult females with Hodgkin’s disease, Is there an impact on outcome?
Authors:
- Asmaa Hamoda
- samah semary
- eman naguib
- Madeeha A.T. El Wakeel
- mohamed zaghloul
- salma abdelaziz
- mahmoud hamza
- Emad Moussa
View full abstract at Hemasphere…
P099: PET/CT Response Assessment in Pediatric Hodgkin Lymphoma. Deauville Score 3 Does it really reflect Negativity?
Authors:
- Emad Moussa
- Asmaa Hamoda
- samah semary
- maram salama
- mona fakhry
- maha mehesen
- madeeha elwakeelc
- eman naguib
- amr elnashar
- asmaa Attia
- mohamed sedky
View full abstract at Hemasphere…
P100: Prognostic Significance of PD1, PD-L1 Expression, Pathological Subtypes and Metabolic Activity on 18F-FDG PET/CT in Refractory/Relapsing Pediatric Hodgkin Lymphoma
Authors:
- Reham Khedr
- Eman Khorshed
- Omneya Hassanein
- Hany Abdelrahman
- Madeeha A.T. El Wakeel
- Mohamed Zaghloul
- Asmaa Hamoda
View full abstract at Hemasphere…
P101: Towards Incorporation of Pediatric Specific Criteria in the Revised Lugano Classification of Hodgkin Lymphoma (HL) Staging and Response: Report from the ICML Pediatric Subcommittee
Authors:
- Kara M. Kelly
- Jamie E. Flerlage
- Bradford S. Hoppe
- Regine Kluge
- Christine Mauz-Körholz
- Wilhelm Wößmann
View full abstract at Hemasphere…
P102: Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma: A Sub-Study of Children’s Oncology Group AHOD0431
Authors:
- Bradford S. Hoppe
- Sarah Milgrom
- Lindsay A. Renfro
- Yue Wu
- Cindy Schwartz
- Louis Constine
- David Hodgson
- Kathleen McCarten
- Kara M. Kelly
- Frank G. Keller
- Sharon M. Castellino
View full abstract at Hemasphere…
P103: Updated Results From the Phase 2 KEYNOTE-667 Study: Pembrolizumab (pembro) in Children and Young Adults With High-Risk Classical Hodgkin Lymphoma (cHL) With Slow Early Response (SER) to Front-Line Chemotherapy (chemo)
Authors:
- Christine Mauz-Körholz
- Luciana Vinti
- Stephen Daw
- Antony Ceraulo
- Gerard Michel
- Michaela Cepelova
- Constantino Sabado Alvarez
- Franca Fagioli
- Stephane Ducassou
- Salvatore Buffardi
- Thierry Leblanc
- Bradford S. Hoppe
- Frank G. Keller
- Kara M. Kelly
- Lisa Giulino-Roth
- Judith Landman-Parker
- Juan Shen
- Pallavi Pillai
- Rushdia Yusuf
- Auke Beishuizen
View full abstract at Hemasphere…

Biology and microenvironment

T025: Characterization of cancer-associated fibroblasts and their spatial architecture reveals heterogeneity and survival associations in classical Hodgkin lymphoma
Authors:
- Kristiina Karihtala
- Suvi-Katri Leivonen
- Teijo Pellinen
- Marja-Liisa Karjalainen-Lindsberg
- Tomohiro Aoki
- Christian Steidl
- Sirpa M. Leppä
View full abstract at Hemasphere…
Abstract Talk in “Biology & Microenvironment”
T026: Circulating tumor DNA sequencing facilitates biological classification and individualized risk stratification in patients with Hodgkin lymphoma
Authors:
- Jan-Michel Heger
- Laman Mammadova
- Julia Mattlener
- Sophia Sobesky
- Melita Cirillo
- Janine Altmüller
- Elisabeth Kirst
- Sarah Reinke
- Wolfram Klapper
- Paul J. Bröckelmann
- Justin Ferdinandus
- Helen Kaul
- Gundolf Schneider
- Jessica Schneider
- Julia Katharina Schleifenbaum
- Roland T. Ullrich
- Max Freihammer
- Sabine Awerkiew
- Mia Lohmann
- Florian Klein
- Peter Nürnberg
- Michael Hallek
- Davide Rossi
- Christine Mauz-Körholz
- Stefan Gattenlöhner
- Andreas Bräuninger
- Peter Borchmann
- Bastian von Tresckow
- Sven Borchmann
View full abstract at Hemasphere…
Abstract Talk in “Biology & Microenvironment”
T027: Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma
Authors:
- Ajay Subramanian
- Shengqin Su
- Jamie E. Flerlage
- Stefan K. Alig
- Sheren Younes
- Lianna Marks
- Chelsea Pinnix
- Francisco Vega
- Raphael E. Steiner
- Priya Kumar
- Heidi Mocikova
- Alice Sykorova
- Vit Prochazka
- Cristiane Milito
- Pamela B. Allen
- Darina Paulino
- Alan Ramsay
- Timothy Flerlage
- Monica Palese
- Robert West
- ChunFang Zhu
- Joseph Schroers-Martin
- Troy Noordenbos
- Natalie Park
- Anusha Kalbasi
- Everett Moding
- Aaron Newman
- Ranjana H. Advani
- Richard Hoppe
- Maximilian Diehn
- Yaso Natkunam
- Ash A. Alizadeh
- Michael Binkley
View full abstract at Hemasphere…
Abstract Talk in “Biology & Microenvironment”
T028: Multi-Dimensional Profiling Unveils Distinct Molecular Subtypes in Classic Hodgkin Lymphoma
Authors:
- Tomohiro Aoki
- Gerben Duns
- Shinya Rai
- Andrew Lytle
- Yifan Yin
- Aixiang Jiang
- Stefan K. Alig
- Mohammad Shahrokh Esfahani
- Clementine Sarkozy
- Stacy Hung
- Katy Milne
- Adele Telenius
- Makoto Kishida
- Michael Li
- Luke O` Brien
- Celia Strong
- Talia Goodyear
- Juan Patino Rangel
- Michael Hong
- Shaocheng Wu
- Katsuyoshi Takata
- Tomoko Miyata-Takata
- Merrill Boyle
- Susana Ben-Neriah
- Andrew P. Weng
- Andrew Roth
- Michael Crump
- John Kuruvilla
- Anca Prica
- Robert Kridel
- Brad H. Nelson
- Pedro Farinha
- Ash A. Alizadeh
- Kerry J. Savage
- David W. Scott
- Christian Steidl
View full abstract at Hemasphere…
Abstract Talk in “Biology & Microenvironment”
P029: A novel in vitro model to study the effect of PD1 inhibition in Hodgkin Lymphoma at a molecular level
Authors:
- Rodrigo Martinez Alcala
- Yajie Lei
- Lydia Visser
- Arjan Diepstra
- Johanna Veldman
View full abstract at Hemasphere…
P030: Cell-Free DNA as Potential Prognosticator and Tracking Tool in Classic Hodgkin Lymphoma: Molecular Profiling and Clinical Correlations.
Authors:
- Nick Veltmaat
- Geok Wee Tan
- Yujie Zhong
- Sophie Teesink
- Martijn Terpstra
- Johanna Bult
- Marcel Nijland
- Joost Kluiver
- Arjan Diepstra
- Anke van den Berg
- Wouter J. Plattel
View full abstract at Hemasphere…
P031: Characteristics and outcomes of patients with Hodgkins Lymphoma with Paraneoplastic manifestations
Authors:
- Charanpreet Singh
- Lekshmon K S
- Arihant Jain
- Alka Khadwal
- Amanjit Bal
- Radhika Srinivasan
- Rajender K Basher
- Pankaj Malhotra
- Gaurav Prakash
View full abstract at Hemasphere…
P032: CK2 FAVORS T-CELL CHEMOTAXIS THROUGHT THE RELEASE OF SOLUBLE FACTORS BY HODGKIN AND REED–STERNBERG CELLS
Authors:
- Andrea Visentin
- Federica Frezzato
- Guido Capasso
- Nayla Mouawad
- Maria Castronuovo
- Alessandro Cellini
- Francesco Angotzi
- Andrea Serafin
- Chiara Adele Cavarretta
- Valeria Ruocco
- Arianna Bevilacqua
- Sabrina Manni
- Monica Facco
- Federico Scarmozzino
- Marco Pizzi
- Fabrizio Vianello
- Francesco Piazza
- Livio Trentin
View full abstract at Hemasphere…
P033: Final analysis of correlation between serum TARC concentration and MTV,TLG in a cohort of Classical Hodgkin lymphoma during first line treatment.
Authors:
- Benedetta Sordi
- Ciceri Manuel
- Leonardo Signori
- Elisabetta Abenavoli
- Aurora Lombardo
- Ilaria Romano
- Marianna Palazzo
- Giacomo Coltro
- Michela Zizza
- Fabiana Pancani
- Luca Nassi
- Benedetta Puccini
View full abstract at Hemasphere…
P034: Gene Expression Signature Reveals a Protective Role of B-cells in the Progression of classical Hodgkin Lymphoma patients
Authors:
- Benedetta Donati
- Tanja Lazic
- Maria Elena Nizzoli
- Alberto Bavieri
- Rexhep Durmo
- Riccardo Valli
- Attilio Gennaro
- Cristian Ascione
- Alessia Ruffini
- Stefano Pozzi
- Annibale Versari
- Francesco Merli
- Alessia Ciarrocchi
- Stefano Luminari
View full abstract at Hemasphere…
P035: Histological Grading in Nodular Sclerosis Classical Hodgkin Lymphoma Identifies a Subgroup of Patients with Higher Early Response Rates and Better Prognosis in the Contemporary Treatment Era
Authors:
- Alessandro Cellini
- Federico Scarmozzino
- Chiara Adele Cavarretta
- Francesco Angotzi
- Valeria Ruocco
- Andrea Serafin
- Nicolò Danesin
- Michele Gregianin
- Stefania Vio
- Filippo Crimì
- Federica Vianello
- Francesco Piazza
- Marco Pizzi
- Livio Trentin
- Andrea Visentin
View full abstract at Hemasphere…
P036: Immune landscape associated with response to brentuximab vedotin with ipilimumab and/or nivolumab in relapsed Hodgkin lymphoma in E4412 Phase 1
Authors:
- Catherine Diefenbach
- Edgar Gonzalez-Kozlova
- Diane Marie Del Valle
- Hsin-Hui Huang
- Opeyemi Jegede
- Vanessa Barcessat
- Kevin Tuballes
- Geoffrey Kelly
- Manishkumar Patel
- Hui Xie
- Jocelyn Harris
- Kimberly Argueta
- Kai Nie
- Kai Nie
- Radim Moravec
- Jen Altreuter
- Dzifa Yawa Duose
- Brad S. Kahl
- Stephen M. Ansell
- Jocye Yu
- Ethan Cerami
- James Lindsay
- Ignacio Wistuba
- Seunghee Kim-Schulze
- Sacha Gnjatic
View full abstract at Hemasphere…
P037: Impact of Clonal hematopoiesis of indeterminate potential in classical Hodgkin lymphoma
Authors:
- Caroline Hesselager
- Peter Hollander
- Ann-Sofie Johansson
- Johan Linderoth
- Gunilla Enblad
- Simone Weström
- Daniel Eriksson
- Arielle R Munters
- Daniel Molin
- Panagiotis Baliakas
- Rose-Marie Amini
View full abstract at Hemasphere…
P038: Molecular pathogenesis of Hodgkin lymphoma
Authors:
- Lilian Beeck
- Bettina Budeus
- Markus Schneider
- Navid Farsijani
- Julia Bein
- Sylvia Hartmann
- Martin-Leo Hansmann
- Ralf Küppers
View full abstract at Hemasphere…
P039: New understanding of oncogenic mechanisms in classical Hodgkin lymphoma
Authors:
- Maria Cristina Pirosa
- Matin Salehi
- Alessio Bruscaggin
- Lodovico Terzi di Bergamo
- Federico Jauk
- Gabriela Forestieri
- Simone Bocchetta
- Deborah Piffaretti
- Riccardo Moia
- Vanessa Cristaldi
- Martina di Trani
- Georgia Alice Galimberti
- Katia Pini
- Valeria Spina
- Claudia Giordano
- Adalgisa Condoluci
- Salvatore Annunziata
- Fabrizio Bergesio
- Renzo Boldorini
- Eugenio Borsatti
- Pietro Bulian
- Stephane Chauvie
- Marco Cuzzocrea
- Bernhard Gerber
- Michał Kurlapski
- Luigi Maria Larocca
- Andrea Rinaldi
- Marcello Rodari
- Grzegorz Romanowicz
- Gian Mauro Sacchetti
- Anastasios Stathis
- Georg Stüssi
- Ilaria Zangrilli
- Eleonora Calabretta
- Francesco Corrado
- Antonio Pinto
- Luca Mazzucchelli
- Valter Gattei
- Jan Maciej Zaucha
- Armando Santoro
- Stefan Hohaus
- Franco Cavalli
- Emanuele Zucca
- Gianluca Gaidano
- Carmelo Carlo‐Stella
- Alexandar Tzankov
- Luca Ceriani
- Davide Rossi
View full abstract at Hemasphere…
P040: Plasma proteins and Hodgkin's lymphoma: Proteome-wide Mendelian randomization and colocalization analyses
Authors:
- Tao Pan
- Jiyue Zhang
- Xiaomin Wang
- Yuqin Song
View full abstract at Hemasphere…
P041: Proteomic profile in classical Hodgkin Lymphoma patients with high inflammation
Authors:
- Jeremia Collin
- Ragnhild Risebro
- Johan Mattsson Ulfstedt
- Emma Pettersson
- Mats Hellström
- Ingrid Glimelius
- Mattias Berglund
- Gunilla Enblad
- Eva Freyhult
- Daniel Molin
View full abstract at Hemasphere…
P042: Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity
Authors:
- Maja Dam Andersen
- Katharina Wolter
- Marie Hairing Enemark
- Kristina Lystlund Lauridsen
- Stephen Jacques Hamilton-Dutoit
- Jørn Starklint
- Francesco d'Amore
- Maja Ludvigsen
- Bent Honoré
- Peter Kamper
View full abstract at Hemasphere…
P043: SPATIAL ORGANIZATION OF THE TUMOR MICROENVIRONMENT IN NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA AND T-CELL/HISTIOCYTE-RICH LARGE B-CELL LYMPHOMA: INSIGHTS FROM A PILOT COHORT STUDY
Authors:
- Ilja Kalashnikov
- Kerttu Kalander
- Ada Junquera
- Matias Autio
- Suvi-Katri Leivonen
- Johannes Dunkel
- Anniina Färkkilä
- Sirpa M. Leppä
View full abstract at Hemasphere…
P044: Sulforaphane, a Natural Compound, Inhibits Cell Growth and Promotes NK Cell-Mediated Anti-Tumor Immune Responses Through cGAS-STING Pathway in Classical Hodgkin Lymphoma
Authors:
- Ioanna Xagoraris
- Ying Yang
- Erofili Bougka
- Dora Trogrlic
- Persa Xyderou
- Konstantina Stathopoulou
- Christina An Bihn Nordentoft
- Nikolas Herold
- Andreas Lundqvist
- Georgios Z. Rassidakis
View full abstract at Hemasphere…
P045: T-cell diversity and exclusion of blood-derived clonally expanded T-cells in the tumor microenvironment of classical Hodgkin Lymphoma
Authors:
- Nicole Seifert
- Sarah Reinke
- Johanna Grund
- Berit Müller-Meinhard
- Julia Richter
- Thorsten Heilmann
- Hans Schlößer
- Michaela Biehl-Kotrova
- Monika Brüggemann
- Peter Borchmann
- Paul J. Bröckelmann
- Michael Altenbuchinger
- Wolfram Klapper
View full abstract at Hemasphere…
P046: Transcriptional reprogramming by mutated IRF4 in lymphoma
Authors:
- Nikolai Schleussner
- Pierre Cauchy
- Vedran Franke
- Maciej Giefing
- Oriol Fornes
- Naveen Vankadari
- Salam Assi
- Mariantonia Costanza
- Marc A. Weniger
- Altuna Akalin
- Ioannis Anagnostopoulos
- Thomas Bukur
- Marco Casarotto
- Frederik Damm
- Oliver Daumke
- Benjamin Edginton-White
- Christof Gebhardt
- Michael Grau
- Stephan Grunwald
- Martin-Leo Hansmann
- Sylvia Hartmann
- Lionel Huber
- Eva Kärgel
- Simone Lusatis
- Daniel Nörenberg
- Nadine Obier
- Ulrich Pannicke
- Anja Pfaus
- Anja Reisser
- Andreas Rosenwald
- Klaus Schwarz
- Srinivasan Sundararaj
- Andre Weilemann
- Wiebke Winkler
- Wendan Xu
- Georg Lenz
- Klaus Rajewsky
- Wyeth Wassermann
- Peter Cockerill
- Claus Scheidereit
- Reiner Siebert
- Ralf Küppers
- Rudolf Grosschedl
- Martin Janz
- Constanze Bonifer
- Stephan Mathas
View full abstract at Hemasphere…
P047: Trial in Progress: Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma (NAHL)
Authors:
- Harsh Shah
- Boyu Hu
- Ken Boucher
- Deborah Stephens
View full abstract at Hemasphere…
P048: Tumor-associated macrophages correlate with skeletal involvement in classic Hodgkin lymphoma
Authors:
- Maja Dam Andersen
- Katharina Wolter
- Marie Hairing Enemark
- Mette Abildgaard Pedersen
- Lars Christian Gormsen
- Kristina Lystlund Lauridsen
- Jørn Starklint
- Stephen Jacques Hamilton-Dutoit
- Francesco d'Amore
- Maja Ludvigsen
- Peter Kamper
View full abstract at Hemasphere…

Older patients

T074: A simplified frailty score predicts outcome in older patients with classical Hodgkin lymphoma treated with curative intent
Authors:
- Kjersti Lia
- Rasmus Rask KJ
- Bente L. Wold
- Øystein Fluge
- Unn-Merete Fagerli
- Hanne Bersvendsen
- Idun B.Bø
- Sameer Bhargava
- Alexander Fosså
View full abstract at Hemasphere…
Abstract Talk in “Older Patients”
T075: Characterisation of older Hodgkin Lymphoma patients using UK registry data from 1997-2023
Authors:
- Aisling Barrett
- Zhe Wang
- Andrew Challenger
- Sarah Darby
- John Broggio
- David Cutter
View full abstract at Hemasphere…
Abstract Talk in “Older Patients”
T076: Feasibility and Efficacy of PET-guided BrECADD in Older Patients with Advanced-Stage classical Hodgkin Lymphoma: The Older Cohort of the International GHSG HD21 Trial
Authors:
- Justin Ferdinandus
- Helen Kaul
- Alexander Fosså
- Andreas Hüttmann
- Felix Keil
- Yon-Dschun Ko
- Felicitas Hitz
- Stefanie Kreissl
- Michael Fuchs
- Dennis A. Eichenauer
- Bastian von Tresckow
- Peter Borchmann
- Paul J. Bröckelmann
View full abstract at Hemasphere…
Abstract Talk in “Older Patients”
T077: Nivolumab-AVD improves 2-year progression-free and overall survival compared to Bv-AVD in older patients aged ≥60 years with advanced stage classical Hodgkin lymphoma (cHL) enrolled on SWOG S1826
Authors:
- Sarah Rutherford
- Hongli Li
- Alex F. Herrera
- Michael LeBlanc
- Sairah Ahmed
- Kelly Davison
- Carla Casulo
- Nancy L. Bartlett
- Joseph Tuscano
- Brian Hess
- Pallawi Torka
- Pankaj Kumar
- Ryan Jacobs
- Joo Song
- Sharon M. Castellino
- Brad S. Kahl
- John Leonard
- Sonali Smith
- Jonathan W. Friedberg
- Andrew Evens
View full abstract at Hemasphere…
Abstract Talk in “Older Patients”
P078: ‘ACOPP’ chemotherapy for older and less fit patients with Hodgkin lymphoma – a multicentre, retrospective study
Authors:
- Matthew Wilson
- Euan Haynes
- Katrina Parsons
- David Hopkins
- Elizabeth Robertson
- Graeme Ferguson
- Daire Quinn
- Jim Murray
- Wendy Osborne
- Mike Leach
- Pam McKay
View full abstract at Hemasphere…
P079: Anthracycline-based therapy for elderly HL patients : a retrospective series from a single South Italy center.
Authors:
- Vittoria Tarantino
- Marika Porrazzo
- Monica Maria Agata Leone
- Ernesto Torretta
- Antonino Mulè
- Caterina PATTI
- Luca Castagna
View full abstract at Hemasphere…
P080: Brentuximab vedotin monotherapy is a feasible and effective treatment in elderly and frail patients with classical Hodgkin lymphoma: Results of the prospective GHSG-NLG phase II BVB trial.
Authors:
- Alexander Fosså
- Daniel Molin
- Paul J. Bröckelmann
- Gundolf Schneider
- Ulf Schnetzke
- Johan Linderoth
- Peter Kamper
- Sirpa M. Leppä
- Julia Meissner
- Valdete Schaub
- Kjersti Lia
- Michael Fuchs
- Peter Borchmann
- Boris Böll
View full abstract at Hemasphere…
P081: Brentuximab vedotin, Cyclophosphamide, Doxorubicin and Prednisone (B-CAP) First-Line Treatment of Advanced-Stage Hodgkin Lymphoma: Final Results of the GHSG-NLG Phase II BVB Trial
Authors:
- Paul J. Bröckelmann
- Boris Böll
- Daniel Molin
- Gundolf Schneider
- Sirpa M. Leppä
- Julia Meissner
- Peter Kamper
- Martin Hutchings
- Jacob Haaber Christensen
- Ulf Schnetzke
- Michael Fuchs
- Dennis A. Eichenauer
- Bastian von Tresckow
- Helen Kaul
- Peter Borchmann
- Alexander Fossa
View full abstract at Hemasphere…
P082: Elderly Classical Hodgkin Lymphoma: Croatian Cooperative Group for Hematological Diseases (KroHem) Experience
Authors:
- Ida Hude Dragičević
- Ida Ivek
- Sandra Bašić-Kinda
- Karla Mišura Jakobac
- Marija Ivić Čikara
- Marija Petrić
- Vlatka Periša
- Ivana Vučinić Ljubičić
- Ivana Sušac Zrna
- Ivan Krečak
- Dina Mokwa
- Tomislav Čolak
- Barbara Dreta
- Dino Dujmović
- Igor Aurer
View full abstract at Hemasphere…
P083: Hodgkin Lymphoma in Older Patients (HoOP)- A European Retrospective Study
Authors:
- Aisling Barrett
- Amy A. Kirkwood
- Cathy Burton
- Ruth Clifford
- Robert Henderson
- Pam McKay
- Wendy Osborne
- Nimish Shah
- Graham P. Collins
View full abstract at Hemasphere…
P084: Patients over the age of 60 years treated with Hodgkin's lymphoma at our Clinic
Authors:
- Dávid Tóthfalusi
- László Imre Pinczés
- Boglárka Dobó
- Árpád Illés
- Zsófia Miltényi
View full abstract at Hemasphere…
P085: Treatment Efficacy, Overall Survival, and Disease-Free Survival in Elderly versus Younger Patients with Hodgkin's Lymphoma: A Decade of Experience at a Latin American Reference Hospital
Authors:
- Gerardo Santiago Jimenez
- Alonso Hernández Company
- Karen Torres Castellanos
- Gilberto Israel Barranco Lampón
- Juan Francisco Zazueta Pozos
- Daniela de Jesús Pérez Sámano
- Emmanuel Martínez Moreno
- Carlos Martínez Murillo
- Adán Germán Gallardo
- Omar Ramos Peñafiel Christian
View full abstract at Hemasphere…

Advanced stages

T001: 2-Year Follow-up of the S1826 Study Confirms Improved Progression-Free Survival with Nivolumab-AVD Compared to Brentuximab Vedotin-AVD in Advanced Stage Classic Hodgkin Lymphoma
Authors:
- Alex F. Herrera
- Michael LeBlanc
- Sharon M. Castellino
- Hongli Li
- Sarah Rutherford
- Andrew Evens
- Kelly Davison
- Angela Punnett
- Susan K. Parsons
- Sairah Ahmed
- Carla Casulo
- Nancy L. Bartlett
- Joseph Tuscano
- Matthew Mei
- Brian Hess
- Ryan Jacobs
- Hayder Saeed
- Pallawi Torka
- Boyu Hu
- Craig H. Moskowitz
- Supreet Kaur
- Gaurav Goyal
- Christopher Forlenza
- Andrew Doan
- Adam Lamble
- Pankaj Kumar
- Saeeda Chowdury
- Brett Brinker
- Namita Sharma
- Avina Singh
- Kristie Blum
- Anamarija Perry
- Alexandra Kovach
- David Hodgson
- Louis Constine
- Lale Kostakoglu
- Anca Prica
- Hildy Dillon
- Richard F. Little
- Margaret A. Shipp
- Michael Crump
- Brad S. Kahl
- John Leonard
- Sonali Smith
- Kara M. Kelly
- Jonathan W. Friedberg
View full abstract at Hemasphere…
Abstract Talk in “Advanced Stages”
T002: Development and application of a validated MRD assay in Hodgkin Lymphoma
Authors:
- Julia Mattlener
- Jessica Schneider
- Julia Katharina Schleifenbaum
- Max Freihammer
- Olivia Käsgen
- Kerstin Becker
- Hodgkin Lymphoma MRD Consortium
- Justin Ferdinandus
- Helen Kaul
- Gundolf Schneider
- Peter Borchmann
- Jan-Michel Heger
- Sven Borchmann
View full abstract at Hemasphere…
Abstract Talk in “Advanced Stages”
T003: EORTC-1537-COBRA: PHASE II STUDY OF VERY EARLY FDG-PET-RESPONSE ADAPTED TARGETED THERAPY FOR ADVANCED HODGKIN LYMPHOMA. PRIMARY ANALYSIS INCLUDING VALUE OF QUANTITATIVE PET ASSESSMENT AND TARC DYNAMICS
Authors:
- Martin Hutchings
- Sophie Teesink
- Anna Sureda-Balari
- Susana Carvalho
- Andrej Vranovsky
- Walter Noordzij
- Annika Loft
- Anne I. J. Aarens
- Wendy Stevens
- Arjan Diepstra
- Berthe M.P. Aleman
- Sherida Woei-A-Jin
- Maria Viguria
- Kirsten Saevels
- Liane Te Boome
- Sanne Tonino
- Paul Meijnders
- Eva Domingo-Domènech
- Caroline Hasselbalch Riley
- Sarah Nuyens
- Cedric Mallien
- Ward Sents
- Emanuel Buhrer
- Catherine Fortpied
- Wouter J. Plattel
View full abstract at Hemasphere…
Abstract Talk in “Advanced Stages”
T004: Metabolic tumor volume after two cycles of chemotherapy in patients treated for advanced-stage Hodgkin Lymphoma: analysis of the German Hodgkin Study Group phase III HD18 and HD21 trials
Authors:
- Justin Ferdinandus
- Helen Kaul
- Gundolf Schneider
- Michael Fuchs
- Hans-Theodor Eich
- Johannes Rosenbrock
- Christian Baues
- Katrin S. Roth
- Alexander Drzezga
- Lutz van Heek
- Markus Dietlein
- Peter Borchmann
- Carsten Kobe
View full abstract at Hemasphere…
Abstract Talk in “Advanced Stages”
P005: Accuracy of Ann Arbor Stage Assignment Based on PET/CT Reports Using a Large Language Model in Hodgkin Lymphoma Patients
Authors:
- Conrad-Amadeus Voltin
- Jonathan Kottlors
- Peter Borchmann
- Philipp Gödel
- Alexander Drzezga
- Markus Dietlein
- Thomas Dratsch
View full abstract at Hemasphere…
P006: Adaptation of a PET-based treatment strategy and outcomes of patients with Advanced Hodgkins Lymphoma in resource constrained settings
Authors:
- Charanpreet Singh
- K. S. Lekshmon
- Arihant Jain
- Alka Khadwal
- Amanjit Bal
- Radhika Srinivasan
- Rajender K Basher
- Pankaj Malhotra
- Gaurav Prakash
View full abstract at Hemasphere…
P007: Are Four Cycles of BEACOPP Escalated Sufficient for Patients with Advanced Hodgkin Lymphoma and PET-2 Deauville Score 3?
Authors:
- Heidi Mocikova
- Jana Markova
- Lubica Gaherova
- Maria Maco
- Eva Maule
- Jozef Michalka
- Andrea Janikova
- Alice Sykorova
- Pavla Stepankova
- Katarina Hradska
- Juraj Duras
- Alexandra Kredatusova
- Vit Prochazka
- Zdenek Kral
- Tomas Kozak
View full abstract at Hemasphere…
P008: Brentuximab Vedotin (BV) Exposure and Long-Term Efficacy Analysis in Patients With Classical Hodgkin’s Lymphoma (cHL): Analysis of Phase 3 ECHELON-1 Study
Authors:
- Zufei Zhang
- Daping Zhang
- Fei Jie
- Keenan Fenton
- Evelyn Rustia
- Consuelo Glenn
- Michelle Fanale
- Tatyana Feldman
- Stephen M. Ansell
- Yen-Lin Chia
View full abstract at Hemasphere…
P009: Brentuximab vedotin plus chemotherapy in patients with previously untreated Stage III/IV classical Hodgkin lymphoma: seven-year overall survival analysis from ECHELON-1
Authors:
- Martin Hutchings
- Stephen M. Ansell
- David J. Straus
- Joseph M. Connors
- Wojciech Jurczak
- Won-Seog Kim
- Andrea Gallamini
- Radhakrishnan Ramchandren
- Jonathan W. Friedberg
- Ranjana H. Advani
- Andrew M. Evens
- Kerry J. Savage
- Hyeon-Seok Eom
- Tatyana Feldman
- Jeremy S. Abramson
- Cassie Dong
- Bipin Savani
- Athanasios Zomas
- Keenan Fenton
- John Radford
View full abstract at Hemasphere…
P010: Clinico-pathological correlation in patients with positive end of treatment PET after pembrolizumab + AVD for untreated classic Hodgkin lymphoma
Authors:
- Ryan Lynch
- Kikkeri Naresh
- Ridvan Demirci
- Delphine Chen
- Chaitra Ujjani
- Christina Poh
- Edus H. Warren
- Stephen Smith
- Mazyar Shadman
- Brian Till
- Vikram M. Raghunathan
- Yolanda Tseng
- Ajay K. Gopal
View full abstract at Hemasphere…
P011: Data Collaborations Accelerate Pediatric Hodgkin Lymphoma Research Through NODAL
Authors:
- Flerlage Jamie
- Suzi Birz
- Sharon M. Castellino
- Tara O. Henderson
- John Lucas
- Lindsay A. Renfro
- Yiwang Zhou
- Samuel Volchenboum
- Brian Furner
- Michael Watkins
- Kara M. Kelly
View full abstract at Hemasphere…
P012: Exploring the capability of the Advanced-Stage Hodgkin Lymphoma International Prognostic Index to predict the lack of an early complete metabolic response in a multicentric Italian cohort
Authors:
- Alessandro Cellini
- Giovanni Manfredi Assanto
- Alessandra Romano
- Gabriella Santuccio
- Candida Vitale
- Maria Chiara Montalbano
- Chiara Adele Cavarretta
- Francesco Angotzi
- Valeria Ruocco
- Andrea Serafin
- Nicolò Danesin
- Marta Coscia
- Francesco Di Raimondo
- Ilaria Del Giudice
- Francesco Piazza
- Livio Trentin
- Andrea Visentin
View full abstract at Hemasphere…
P013: High rates of undetectable MRD by PhasED-Seq on interim and end of treatment timepoints in untreated advanced stage CHL treated with pembrolizumab + AVD
Authors:
- Ryan Lynch
- Stefan K. Alig
- Chaitra Ujjani
- Christina Poh
- Edus H. Warren
- Stephen Smith
- Mazyar Shadman
- Brian Till
- Vikram M. Raghunathan
- Yolanda Tseng
- Susan Ottemiller
- Bonnie Joy
- Melissa Fessel
- Hongyan Du
- Jackie Vandermeer
- Alyssa Kelly
- Heather Rasmussen
- Jenna Voutsinas
- Ash A. Alizadeh
- Ajay K. Gopal
View full abstract at Hemasphere…
P014: Hodgkins Lymphoma in Latin American patients: Ten years experience in a reference center in Mexico.
Authors:
- Alonso Hernández Company
- Gerardo Santiago Jiménez
- Karen Torres Castellanos
- Gilberto Israel Barranco Lampón
- Juan Francisco Zazueta Pozos
- Daniela de Jesús Pérez Sámano
- Emmanuel Martínez Moreno
- Adán Germán Gallardo Rodríguez
- Carlos Martínez Murillo
- Omar Ramos Peñafiel Christian
View full abstract at Hemasphere…
P015: Identification of Risk Categories and Stratification from the Advanced-Stage Hodgkin Lymphoma (AS-HL) International Prognostic Index (A-HIPI) Model
Authors:
- Matthew Maurer
- Susan K. Parsons
- Jenica Upshaw
- Angie Mae Rodday
- Jonathan W. Friedberg
- Andrea Gallamini
- Massimo Federico
- Eliza Hawkes
- David Hodgson
- Peter Johnson
- Eric Mou
- Kerry Savage
- Pier Luigi Zinzani
- Andrew Evens
View full abstract at Hemasphere…
P016: Implementing BrECADD for the treatment of adult patients with newly diagnosed advanced stage classical Hodgkin’s lymphoma (AS-cHL). A single center experience
Authors:
- Athanasios Gakopoulos
- Chara Giatra
- Michael Panousieris
- Sotiris Bristogiannis
- Athanasia Apsemidou
- Antonia Mitkou
- Christos Masaoutis
- Ioannis Baltadakis
- Maria Bouzani
View full abstract at Hemasphere…
P017: INDIRECT CLINICAL TRIALS COMPARISONS OF TREATMENTS FOR ADVANCED-STAGED HODGKIN LYMPHOMA WITH INDIVIDUAL PATIENT DATA EXTRACTION.
Authors:
- Andrea Visentin
- Alessandro Cellini
- Francesco Angotzi
- Valeria Ruocco
- Andrea Serafin
- Nicolò Danesin
- Arianna Bevilacqua
- Chiara Adele Cavarretta
- Francesco Piazza
- Livio Trentin
View full abstract at Hemasphere…
P018: Lower doses of dacarbazine as a safer strategy in Hodgkin Lymphoma’s intensive treatment protocol (modified escalated BEACODD): preliminary retrospective analysis of a single and public center in Brazil.
Authors:
- Arthur Gomes Oliveira Braga
- Larissa Hilario Dulley
- Guilherme Garcia Rodrigues
- Sergio Costa Fortier
- Carlos Sergio Chiattone
- Talita Maira Bueno da Silveira
View full abstract at Hemasphere…
P019: Pembrolizumab + AVD in classic Hodgkin lymphoma: Low rates of febrile neutropenia despite frequent grade 4 neutropenia
Authors:
- Thomas Kuczmarski
- Chaitra Ujjani
- Christina Poh
- Edus H. Warren
- Stephen Smith
- Mazyar Shadman
- Brian Till
- Vikram M. Raghunathan
- Yolanda Tseng
- Hongyan Du
- Jackie Vandermeer
- Alyssa Kelly
- Heather Rasmussen
- Jenna Voutsinas
- Ajay K. Gopal
- Ryan Lynch
View full abstract at Hemasphere…
P020: Real-life experience with BV-AVD combination in advanced stage classical Hodgkin Lymphoma: A multicenter study from Greece
Authors:
- Athanasios Liaskas
- Maria Angelopoulou
- Pinelopi Vryttia
- Evgenia Verrou
- Alexia Piperidou
- Maria-Aikaterini Lefaki
- Angeliki Georgopoulou
- Alexandros Machairas
- Dionisios Stoumbos
- Georgia Kaiafa
- Anastasia Sioni
- Nikolaos Kanellias
- Maria Arapaki
- Elianna Constantinou
- Dimitrios Gogos
- Marina Siakantari
- Eirini Katodritou
- Panayiotis Panayiotidis
- Sotirios Papageorgiou
- Theodoros Vassilakopoulos
View full abstract at Hemasphere…
P021: SERUM TARC COMBINED WITH FDG-PET IMAGING IMPROVES INTERIM RESPONSE EVALUATION IN CLASSIC HODGKIN LYMPHOMA: A RETROSPECTIVE ANALYSIS OF GERMAN HODGKIN STUDY GROUP HD16 AND HD18 TRIALS
Authors:
- Wouter J. Plattel
- Janina Jablonski
- Mia Lohmann
- Bastian Von Tresckow
- Anna Sureda
- Michiel Pegtel
- Josée M. Zijlstra
- John Radford
- Bart-Jan Kroesen
- Lydia Visser
- Michael Fuchs
- Peter Borchmann
- Arjan Diepstra
- Sven Borchmann
View full abstract at Hemasphere…
P022: TREATMENT OF CLASSICAL HODGKIN'S LYMPHOMA (cHL) WITH BRENDUXIMAB VEDOTIN - DOXORUBICIN – VINBLASTINE – DACARBAZINE (BV-AVD). ONE CENTER’S EXPERIENCE
Authors:
- Chara Giatra
- Andri Polyviou
- Kyriaki Kontitsi
- Tatiana Tzenou
- Michael Panousieris
- Vasiliki Babali
- Athanasia Apsemidou
- Sotiris Bristogiannis
- Athanasios Gakopoulos
- Evridiki Theodorou
- George Kanellis
- Ioannis Baltadakis
- Stavros Gigantes
- Maria Bouzani
View full abstract at Hemasphere…
P023: Trial In Progress: CTEP 10590, NORM: Nodular lymphocyte-predominant Hodgkin lymphoma patients treated in a randomized phase II trial with either rituximab or mosunetuzumab
Authors:
- Raphael E. Steiner
- Hun Ju Lee
- Michael Green
- Ruitao Lin
- Chelsea Pinnix
- Alison Moskowitz
- Joachim Yahalom
- Dai Chihara
View full abstract at Hemasphere…
P024: Trial in Progress: PRIMAVERA: A Modular Phase I/II Study to Evaluate the Safety, Tolerability, and Efficacy of AZD3470, a Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor, in Participants with Relapsed/Refractory (R/R) Hematologic Malignancies
Authors:
- Tae Min Kim
- Katherine Lewis
- Juan Alderuccio
- Hun Ju Lee
- Enrico Derenzini
- Pier Luigi Zinzani
- Marco Ladetto
- Elizabeth H. Phillips
- Herve Ghesquieres
- François Lemonnier
- Franck Morschhauser
- Anna Sureda-Balari
- Antonia Rodriguez Izquierdo
- Peter Borchmann
- Matthew Weinstock
- Jakub Svoboda
- Emma Dean
- Jelena Urosevic
- Stefanie Meyer
- Robert Chen
- Ting Yu
- Ruben Reyes
- Kaitlyn Beyfuss
- Graham P. Collins
View full abstract at Hemasphere…

Living beyond lymphoma

T062: A priori estimation of mediastinal toxicities after radiotherapy for Hodgkin Lymphoma - A secondary analysis of the HD16/17 Trial by the German Hodgkin Study Group using normal tissue complication probability calculations
Authors:
- Michael Oertel
- Priska Hölscher
- Dominik A. Hering
- Christopher Kittel
- Michael Fuchs
- Niklas B. Pepper
- Stefan Lerch
- Uwe Haverkamp
- Peter Borchmann
- Hans T. Eich
View full abstract at Hemasphere…
Abstract Talk in “Living Beyond Lymphoma”
T063: Concordance between late effects reported by physicians and patients in a cohort of long-term Hodgkin lymphoma survivors: an analysis of data from nine consecutive EORTC-LYSA trials
Authors:
- Sidsel J. Juul
- Sára Rossetti
- Berthe M.P. Aleman
- Flora E. van Leeuwen
- Marleen A.E. van der Kaaij
- Francesco Giusti
- Paul Meijnders
- John M.M. Raemaekers
- Hanneke C. Kluin-Nelemans
- Michele Spina
- Daphne Krzisch
- Camille Bigenwald
- Aspasia Stamatoullas
- Marc André
- Wouter J. Plattel
- Martin Hutchings
- Maja V. Maraldo
View full abstract at Hemasphere…
Abstract Talk in “Living Beyond Lymphoma”
T064: Novel 3D speckel tracking imaging modality in detecting cardiac toxicity in asymptomatic pediatric HL survivors
Authors:
- Zeinab Salah
- Mustafa Selim
- Nesreen Ali
- Antoine Abdelmassih
- Mohammed Mosaad Soliman
- Nahla M El Nabarawy
- Hany Hussein
- Doaa Mohamed Albeltagi
- Iman Sidhom
View full abstract at Hemasphere…
Abstract Talk in “Living Beyond Lymphoma”
P065: An exploration of patient specific and systemic delays as part of the diagnostic odyssey in patients with Hodgkin lymphoma- an analysis of the Lymphoma Coalition’s 2022 Global Patient Survey
Authors:
- Steve Kalloger
- Amanda Watson
- Shawn Sajkowski
- Lorna Warwick
View full abstract at Hemasphere…
P066: Analysis of fetal dose exposure by modern radiation therapy in pregnant patients with supradiaphragmatic Hodgkin lymphoma - A phantom-based simulation
Authors:
- Michael Oertel
- Gina Smeets
- Isabel Vogt
- Heidi Wolters
- Christopher Kittel
- Dominik A. Hering
- Burkhard Greve
- Uwe Haverkamp
- Hans T. Eich
View full abstract at Hemasphere…
P067: Excellent outcomes with low intensity treatment based on age and stage in children and adults with nodular lymphocyte predominant Hodgkin lymphoma (NLPHL): a 10yr retrospective analysis of patients from 8 UK centres.
Authors:
- Thomas Jackson
- Amy A. Kirkwood
- Kushani Ediriwickrema
- Satyen Gohil
- Xiao-Yin Zhang
- Graham P. Collins
- Georgina Hall
- David Hopkins
- Pamela McKay
- Ananth Shankar
- Valeria Fiaccadori
View full abstract at Hemasphere…
P068: Hodgkin’s Lymphoma in Armenia: Diagnostic Delays and the Unintended Benefits of COVID-19 Screening
Authors:
- Lusine Sahakyan
- Diana Soghomonyan
- Astghik Voskanyan
- Arev Stepanyan
- Lusine Stepanyan
- Marina Melik-Andreasyan
- Levon Evoyan
- Miranush Saaryan
View full abstract at Hemasphere…
P069: Male sex and longer time since Hodgkin lymphoma diagnosis are associated with non-attendance at survivorship clinics
Authors:
- Eline M.J. Lammers
- Berthe M.P. Aleman
- Michael Schaapveld
- Josée M. Zijlstra
- Cécile P.M. Janus
- Roel J. de Weijer
- Maaike G.A. Schippers
- Rinske S. Boersma
- Saskia S. Gommers
- Mirjam Kappert
- Flora E. van Leeuwen
- Annelies Nijdam
View full abstract at Hemasphere…
P070: Management and Follow-Up of Pregnancy in Patients Diagnosed with Hodgkin's Lymphoma
Authors:
- Norayr Ghukasyan
- Poghosyan Andranik
- Gharibyan Edita
- Danielyan Lusine
- Sahakyan Lusine
- Marina Melik-Andreasyan
- Heghine Khachatryan
View full abstract at Hemasphere…
P071: MyHodgkin MyHealth (MHMH): Mobile App for patient-entered data to collect long term follow up (LTFU) after Hodgkin Lymphoma (HL) treatment
Authors:
- Nicole Wong Doo
- Janlyn Falconer
- Gajan Kailainathan
- Patrick E. Lawrence
- Georgia Klemm
- Nathan Chapman
- Judith Trotman
View full abstract at Hemasphere…
P072: Study of long-term survivorship of lymphoma patients – a multicenter longitudinal study of return to work and quality of life (ALLY)
Authors:
- Ruth Elisa Eyl-Armbruster
- Julia Wendler
- Ramona Böttinger
- Simone Neumaier
- Antje Jensch
- Markus Knott
- Susanne Rössle
- Nicola Giesen
- Jessika Strentzsch
- Veronika Schindler
- Hans-Georg Kopp
- Jochen Greiner
- Claudio Denzlinger
- Gerald Illerhaus
View full abstract at Hemasphere…
P073: The national Breast screening After Radiotherapy Dataset (BARD) identifies women in England at very high risk (VHR) of breast cancer (BC) following radiotherapy (RT) and ensures timely referral to the correct national screening pathway
Authors:
- John Radford
- Joanna Williams
- Elsita Payne
- Kirstin Roberts
- Jacquie Jenkins
- Anne Mackie
- Aislinn Macklin-Doherty
- Anthony Swerdlow
- Martin McCabe
- Tanya Massey
- Debbie Worthington
- Natalie Yates-Bolton
- Marianne Aznar
- Richard Cowan
- Sacha Howell
View full abstract at Hemasphere…

Relapsed and refractory

T104: Brentuximab Vedotin - ESHAP Significantly Increases the Metabolic Complete Remission Rate versus ESHAP in Relapsed Classical Hodgkin’s Lymphoma. Final Results of the BRESELIBET Prospective Trial.
Authors:
- Anna Sureda
- Javier Núñez Céspedes
- María José Terol Casterá
- Francisca Hernández Mohedo
- Eva Domingo-Domènech
- Fátima de la Cruz Vicente
- Miriam Moreno Velázquez
- M. Elena Amutio Díaz
- Ana Pilar González Rodríguez
- Raúl Córdoba
- Carmen Martínez Muñoz
- Samuel Romero Domínguez
- Mariana Bastos
- Antonia Rodríguez Izquierdo
- Javier Briones Meijide
- Richard Greil
- María Casanova
- Araceli Rubio
- Irit Avivi
- Raquel del Campo García
- Pilar Gómez
- Theodoros Vassilakopoulos
- Sandra Basic-Kinda
- Sotirios Papageorgiou
- Víctor Noriega
- José Javier Sánchez Blanco
- Blanca Sánchez
- Izaskun Zeberio
- Ramón García-Sanz
View full abstract at Hemasphere…
Abstract Talk in “Relapsed & Refractory HL”
T105: Longitudinal circulating tumor DNA sequencing may predict the response to PD1 blockade therapy in relapsed/refractory classical Hodgkin Lymphoma patients
Authors:
- Francesco Corrado
- Eleonora Calabretta
- Martina di Trani
- Martina Sollini
- Vanessa Cristaldi
- Lodovico Terzi di Bergamo
- Alessio Bruscaggin
- Maria Cristina Pirosa
- Marcello Viscovo
- Stefania Bramanti
- Arturo Chiti
- Stefan Hohaus
- Armando Santoro
- Davide Rossi
- Carmelo Carlo‐Stella
View full abstract at Hemasphere…
Abstract Talk in “Relapsed & Refractory HL”
T106: Pembrolizumab maintenance instead of autologous hematopoietic cell transplantation for patients with relapsed or refractory Hodgkin lymphoma in complete response after pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin
Authors:
- Alison Moskowitz
- Gunjan Shah
- Nivetha Ganesan
- Helen Hancock
- Theresa Davey
- Tiffany Chang
- Brittney Munayirji
- Monifa Douglas
- Alayna M. Santarosa
- Alexander Boardman
- Philip Caron
- Kevin David
- Zachary Epstein-Peterson
- Lorenzo Falchi
- Paola Ghione
- Andrew Intlekofer
- Paul Hamlin
- Steven Horwitz
- William Johnson
- Anita Kumar
- Jennifer Lue
- Efrat Luttwak
- Ariela Noy
- Colette Owens
- Maria Palomba
- Gilles Salles
- Raphael E. Steiner
- Robert Stuver
- Pallawi Torka
- Santosha Vardhana
- Andrew Zelenetz
- Joachim Yahalom
- Ahmet Dogan
- Heiko Schoder
- Craig H. Moskowitz
View full abstract at Hemasphere…
Abstract Talk in “Relapsed & Refractory HL”
P107: A short course of nivolumab (N) followed by chemotherapy BGD and autologous transplantation (aHCT) as the salvage treatment for relapsed/refractory (r/r) Hodgkin Lymphoma (cHL) patients – the preliminary results of the N-BURGUND trial of PLRG
Authors:
- Jan Maciej Zaucha
- Ewa Paszkiewicz-Kozik
- Bogdan Małkowski
- Michał Taszner
- Justyna Rybka
- Karolina Chromik
- Agnieszka Kołkowska-Leśniak
- Edyta Subocz
- Łukasz Targoński
- Paulina Ceklarz
- Magdalena Witkowska
- Katarzyna Domańska-Czyż
- Agnieszka Giza
- Małgorzata Kobylecka
- Conrad-Amadeus Voltin
- Joanna Romejko-Jarosińska
- Beata Ostrowska
- Monika Świerkowska
- Agnieszka Druzd-Sitek
- Michał Kurlapski
- Marta Bednarek
- Grzegorz Romanowicz
- Ryszard Swoboda
- Joanna Góra-Tybor
- Janusz Hałka
- Tomasz Wróbel
- Sebastian Giebel
- Grzegorz Helbig
- Ewa Lech-Marańda
View full abstract at Hemasphere…
P108: Abscopal Effect of Radiotherapy and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma: Results of the International GHSG Phase II AERN Trial
Authors:
- Paul J. Bröckelmann
- Ina Bühnen
- Josée M. Zijlstra
- Stephan Mathas
- Katrin S. Roth
- Maria Garcia-Marquez
- Christian Sillaber
- Julia Meissner
- Alexander Fosså
- Richard Greil
- Karolin Trautmann-Grill
- Johannes Rosenbrock
- Wouter J. Plattel
- Hans A. Schlösser
- Carsten Kobe
- Michael Fuchs
- Peter Borchmann
- Christian Baues
View full abstract at Hemasphere…
P109: Are refractory/relapsed Hodgkin lymphoma patients can be recognized earlier?
Authors:
- Boglárka Dobó
- Dávid Tóthfalusi
- László Imre Pinczés
- Zsófia Miltényi
- Árpád Illés
View full abstract at Hemasphere…
P110: Autologous stem cell transplantation in relapsed/refractory classic Hodgkin lymphoma after PD-1 inhibitors salvage regimens is effective in third- or fourth-line therapy
Authors:
- Polina Kotselyabina
- Evgenia Borzenkova
- Andrey Chekalov
- Kirill Lepik
- Liudmila Fedorova
- Artem Ivanov
- Elena Lepik
- Elena Kondakova
- Ivan Moiseev
- Natalia Mikhailova
- Alexander Kulagin
View full abstract at Hemasphere…
P111: C-MOPP chemotherapy is a highly efficacious regimen for patients with relapsed classical Hodgkin lymphoma following PD-1 inhibitor treatment failure.
Authors:
- Stephen Ma
- Shahla Vilcassim
- Pasquale Fedele
- George Grigoriadis
- Michael Low
- Gareth P. Gregory
- Stephen Opat
- Michael Gilbertson
View full abstract at Hemasphere…
P112: Coformulated Favezelimab and Pembrolizumab (pembro) Versus Chemotherapy (chemo) in Patients (Pts) With Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL) Refractory to Anti–PD-1 Therapy: The Phase 3 KEYFORM-008 Study
Authors:
- David Lavie
- John Timmerman
- Ramón García-Sanz
- Won-Seog Kim
- Tae Min Kim
- Abraham Avigdor
- Daan Dierickx
- Deepa Jagadeesh
- Daniel Molin
- Muhit Ozcan
- Omur Gokmen Sevindik
- Hayder Saeed
- Yulia Sidi
- Pallavi Pillai
- Rushdia Yusuf
- Alex F. Herrera
View full abstract at Hemasphere…
P113: Dose-dense Brentuximab Vedotin Plus Ifosfamide, Carboplatin, and Etoposide (ICE) in Second Line Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma: 5-year Long Term Follow Up
Authors:
- Ryan Lynch
- Ryan Cassaday
- Stephen Smith
- Andrew Cowan
- Edus H. Warren
- Mazyar Shadman
- Brian Till
- Chaitra Ujjani
- Karolyn Morris
- Heather Rasmussen
- Jenna Voutsinas
- Ajay K. Gopal
View full abstract at Hemasphere…
P114: Early Progression of Disease Predicts Poor Survival in Patients with Classic Hodgkin Lymphoma: Czech Hodgkin Lymphoma Study Group analysis
Authors:
- Vít Procházka
- Alice Sýkorová
- Alexandra Kredátusová
- Marie Lukášová
- Pavla Štěpánková
- Tomáš Papajík
View full abstract at Hemasphere…
P115: Efficacy and safety of prolgolimab monotherapy or in combination with bendamustine in second-line therapy for r/r classic Hodgkin lymphoma: trial in progress (Prolgo-HL)
Authors:
- Liudmila Fedorova
- Kirill Lepik
- Polina Kotselyabina
- Anastasia Semenova
- Valerie Shpirko
- Stanislav Volchenkov
- Vladislav Markelov
- Andrey Chekalov
- Ilya Zyuzgin
- Gayane Tumyan
- Natalia Mikhailova
- Alexander Kulagin
View full abstract at Hemasphere…
P116: Extended Follow-up from an Intergroup Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma: A trial of the ECOG-ACRIN Research Group (E4412)
Authors:
- Catherine Diefenbach
- Opeyemi Jegede
- Stephen M. Ansell
- Christian Steidl
- Yasodha Natkunam
- David W. Scott
- Neha Mehta-Shah
- Jennnifer E. Amengual
- Christopher J. Forlenza
- Peter Cole
- Nancy L. Bartlett
- Kevin David
- Ranjana H. Advani
- Richard F. Ambinder
- Sachdev P. Thomas
- Sami Ibrahimi
- Brad S. Kahl
View full abstract at Hemasphere…
P117: Frequency and indicators of primary refractoriness in low-risk non-bulky early-stage Hodgkin’s lymphoma patients and negative interim PET – report from the RAFTING trial
Authors:
- Kateryna Filonenko
- Eva Domingo-Domènech
- Javier Nunez
- Cecilia Carpio
- Alessandra Romano
- Corrado Tarella
- Antonia Rodríguez Izquierdo
- Ramon Garcia
- Livio Trentin
- Manuel Gotti
- Michał Kurlapski
- Marta Bednarek
- Andrea Gallamini
- Jan Maciej Zaucha
View full abstract at Hemasphere…
P118: Gemcitabine and Vinorelbine as 3rd line Chemotherapy for Primary Refractory/relapsing Hodgkin Lymphoma-Outcome and Toxicity Profile
Authors:
- Asmaa Hamoda
- reham khedr
- hany abdelrahman
- naglaa elkinaii
- iman zaki
- engy mohamed
View full abstract at Hemasphere…
P119: Inclusion of Brentuximab vedotin in salvage regimens before transplant benefits relapsed/refractory Hodgkin lymphoma patients in a real-world setting - a multicenter study in Portugal
Authors:
- Pedro Santos
- Sara Tavares
- Catarina Costa
- Miguel Neto
- Isabel Paulos Mesquita
- Catarina Silva
- Filipe R. Pinto
- Ana Tomé
- Rita Gerivaz
- Alexandra Monteiro
- Rita Coutinho
- Adriana Roque
- Ana Luísa Pinto
- Margarida Badior
- Teresa Ribeiro
- Marco Dias
- Ana Vagos Mata
- Tatiana Mendes
- Francisca Miranda
- Filipa Mousinho
- Renata Cabral
- Sofia Ramalheira
- Mafalda Alpoim
- Bruno Mesquita
- Francesca Pierdomenico
- Maria Gomes da Silva
View full abstract at Hemasphere…
P120: KEYNOTE-B68: Updated efficacy and safety of pembrolizumab every six weeks in relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL) or primary mediastinal B-cell lymphoma (PMBCL)
Authors:
- Andrew McDonald
- Estelle Verburgh
- Manuel Gotti
- Antonio Pinto
- Jan Maciej Zaucha
- Vladimir Ivanov
- Vladimir Melnichenko
- Heidi Mocikova
- Muhit Ozcan
- Caterina Patti
- João Farias
- Iara Goncalves
- Olha Kuchkova
- Jiri Mayer
- Güray Saydam
- Sarah Tomassetti
- Kumudu Pathiraja
- Katherine Ryland
- Rushdia Yusuf
- Wojciech Jurczak
View full abstract at Hemasphere…
P121: Nivolumab based salvage in Relapsed/Refractory Hodgkin Lymphoma: experience from a tertiary care hospital in north India
Authors:
- Sanjeev Sanjeev
- Deep Gala
- Sauvik Saha
- Manish Kumar Singh
- Aftab Nazar
- Manish ora
- Dinesh chandra
- Khaliqur Rahman
- Ruchi Gupta
- Rajesh Kashyap
View full abstract at Hemasphere…
P122: Open-label phase 1 study to evaluate the safety of SGN-35T in patients with relapsed/refractory CD30-expressing lymphoid malignancies (SGN35T-001; trial in progress)
Authors:
- Tatyana Feldman
- Radhakrishnan Ramchandren
- Hun Ju Lee
- Gizelle Popradi
- Graham P. Collins
- Daniel Morillo
- Mingjin Yan
- Tara L. Chen
- Youn H. Kim
View full abstract at Hemasphere…
P123: Outcome of treatment with the anti-PD-1 monoclonal antibodies nivolumab and pembrolizumab in patients with classical Hodgkin lymphoma — A retrospective analysis on consecutive patients from a well-defined region.
Authors:
- Zaid Mansur
- Elin Lundin
- Lotta Hansson
- Björn Engelbrekt Wahlin
- Marzia Palma
View full abstract at Hemasphere…
P124: Outcomes in patients with relapsed/refractory Hodgkin lymphoma after failure following frontline brentuximab vedotin-based treatment
Authors:
- Shin Yeu Ong
- Lu Chen
- Reid Merryman
- Harsh Shah
- Robert Stuver
- Ann S. LaCasce
- Ayo Falade
- Kelsey Baron
- Nivetha Ganesan
- Tiffany Chang
- Urshila Durani
- Tamer Othman
- Philippe Armand
- Matthew Mei
- Alison J. Moskowitz
- Alex F. Herrera
View full abstract at Hemasphere…
P125: Pembrolizumab and involved site radiation therapy alone as an alternative to transplant in patients with localized failure following chemotherapy for Hodgkin Lymphoma: A prospective multicenter phase II study
Authors:
- Alexandra Dreyfuss
- Nivetha Ganesan
- Alvaro Alencar
- Alexander Boardman
- Philip Caron
- Tiffany Chang
- Theresa Davey
- Kevin David
- Ahmet Dogan
- Zachary Epstein-Peterson
- Lorenzo Falchi
- Beatrice Fregonese
- Paola Ghione
- Paul Hamlin
- Steven Horwitz
- Brandon Imber
- Andrew Intlekofer
- Derek Isrow
- Erel Joffe
- William Johnson
- Anita Kumar
- Michael Lariviere
- Jennifer Lue
- Efrat Luttwak
- Michael McNicholas
- Zachary Moore
- Brittney Munayirji
- Ariela Noy
- Colette Owens
- Lia Palomba
- Jaldhi Patel
- John Plastaras
- Alayna M. Santarosa
- Heiko Schöder
- Gunjan Shah
- Raphael E. Steiner
- Robert Stuver
- Jakub Svoboda
- Pallawi Torka
- Santosha Vardhana
- Andrew Zelenetz
- Gilles Salles
- Joachim Yahalom
- Craig H. Moskowitz
- Alison Moskowitz
View full abstract at Hemasphere…
P126: Pembrolizumab in Combination with Salvage Chemotherapy for First-Relapsed or Refractory Classical Hodgkin Lymphoma: The Multicenter Phase II Pembro-CORE Study (Trial in Progress)
Authors:
- Hishan Tharmaseelan
- Sarah Gillessen
- Ina Bühnen
- Helen Kaul
- Carsten Kobe
- Wolfram Klapper
- Michael Fuchs
- Sven Borchmann
- Paul J. Bröckelmann
- Peter Borchmann
- Bastian von Tresckow
View full abstract at Hemasphere…
P127: Phase II Trial Evaluating the Anti-CD47 Antibody Magrolimab in Combination with Pembrolizumab in Patients with Relapsed / Refractory Classic Hodgkin Lymphoma
Authors:
- Joseph Schroers-Martin
- Michael Spinner
- Reid Merryman
- Cheryl Chang
- Austin Yeung
- Chandley Silin
- May Powell
- Philippe Armand
- Margaret A. Shipp
- Ranjana H. Advani
View full abstract at Hemasphere…
P128: Preliminary Results of the Phase 2 Study Evaluating the Safety and Efficacy of Pembrolizumab (KEytruda) with Bendamustine (TREanda) in Relapsed/Refractory Hodgkin Lymphoma (KEsTREL-01, NCT04510636)
Authors:
- Chathuri Abeyakoon
- Semira Sheikh
- Lisa Wang
- Tomohiro Aoki
- Sita Bhella
- Robert Kridel
- Vishal Kukreti
- Anca Prica
- Abi Vijenthira
- Rob Laister
- Michael Crump
- John Kuruvilla
View full abstract at Hemasphere…
P129: Radiomic and biological biomarkers in relapsed/ refractory classical Hodgkin Lymphoma: an analysis from the ANIMATE study
Authors:
- Aisling Barrett
- Amy A. Kirkwood
- Maria Micaela Vidal
- Victoria Warbey
- Cathy Burton
- Sharon Barrans
- Tracey Mell
- Reuben Tooze
- John R Davies
- David Westhead
- Charlotte Tyson
- Emma Lawrie
- Laura Clifton-Hadley
- Fiona Miall
- Rifca LeDieu
- Elizabeth H. Phillips
- Wendy Osborne
- Dominic Culligan
- Nimish Shah
- Bryson Pottinger
- David Cunningham
- Ruth Pettengell
- Nicolas Martinez-Calle
- Peter Johnson
- Eve Gallop-Evans
- Karl Peggs
- Stephen Booth
- Arzhang Ardavan
- Sally F. Barrington
- Graham P. Collins
View full abstract at Hemasphere…
P130: Response and Survival Results from a Phase II Trial of Pembrolizumab and Entinostat in Relapsed/Refractory Hodgkin Lymphoma
Authors:
- Robert Stuver
- Santosha Vardhana
- Nivetha Ganesan
- Neena Mahajan
- Alexander Boardman
- Philip Caron
- Kevin David
- Zachary Epstein-Peterson
- Lorenzo Falchi
- Paola Ghione
- Paul Hamlin
- Francisco Hernandez-Ilizaliturri
- Steven Horwitz
- Andrew Intlekofer
- William Johnson
- Reem Karmali
- Anita Kumar
- Jennifer Lue
- Efrat Luttwak
- Ariela Noy
- Colette Owens
- Maria Palomba
- Gilles Salles
- Heiko Schoder
- David Sermer
- Raphael E. Steiner
- Pallawi Torka
- Andrew Zelenetz
- Gottfried von Keudell
- Alison Moskowitz
View full abstract at Hemasphere…
P131: Results of allogeneic stem cell transplantation in Hodgkin lymphoma – long term experience.
Authors:
- Zuzana Rusináková
- Andrej Vranovský
- Miriam Ladická
- Silvia Cingeľová
- Ladislav Sopko
- Eva Bojtárová
- Eva Mikušková
- Ľuboš Drgoňa
View full abstract at Hemasphere…
P132: Richter transformation of CLL to Hodgkin lymphoma
Authors:
- Mária Maco
- Heidi Mocikova
- Markéta Kalinová
- Zuzana Prouzová
- Patrik Flodr
- Anna Panovská
- Tomáš Arpáš
- Martin Šimkovič
- Tomáš Kozák
View full abstract at Hemasphere…
P133: Serum TARC monitoring during routine follow-up leads to early diagnosis of relapse in classic Hodgkin lymphoma
Authors:
- Sophie Teesink
- Lydia Visser
- Kylie Keijzer
- Bart-Jan Kroesen
- Marcel Nijland
- Anke van den Berg
- Arjan Diepstra
- Wouter J. Plattel
View full abstract at Hemasphere…
P134: THE BELIEVE STUDY: EFFECTIVENESS AND SAFETY FOR RE-TREATMENT WITH BRENTUXIMAB-VEDOTIN IN RELAPSED/REFRACTORY (R/R) HODGKIN LYMPHOMA: A RETROSPECTIVE MEDICAL CHART REVIEW IN SPAIN. NCT:04998331
Authors:
- Anna Sureda-Balari
- Ramón García-Sanz
- Eva Domingo-Domènech
- Francisco J. Capote
- Antonio Gutierrez
- Antonia Rodríguez Izquierdo
- Marta Grande
- Lourdes Baeza-Montañez
View full abstract at Hemasphere…
P135: The coincidence of relapsed Hodgkin lymphoma and ovarian carcinoma as a role-model for ctDNA MRD monitoring
Authors:
- Veronika Hanáčková
- Jan Grohmann
- Patrik Flodr
- Tomáš Papajík
- Jana Navrátilová
- Vít Procházka
View full abstract at Hemasphere…
P136: The prognostic value of ΔSUVmax and TARC in the first-line treatment of classical Hodgkin lymphoma
Authors:
- László Imre Pinczés
- Dávid Tóthfalusi
- Boglárka Dobó
- Sándor Barna
- Bence Farkas
- Ildikó Garai
- Zsolt Fejes
- Béla Nagy Jr.
- Árpád Illés
- Zsófia Miltényi
View full abstract at Hemasphere…
P137: Updated Analysis of a Phase 1/2 Study Evaluating Pembrolizumab (pembro) Plus the Anti–Lymphocyte-Activation Gene 3 (LAG-3) Antibody Favezelimab for Anti–PD-1–Naive Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL)
Authors:
- Nathalie A. Johnson
- David Lavie
- Peter Borchmann
- Gareth P. Gregory
- Alex F. Herrera
- Leonard Minuk
- Vladan Vucinic
- Philippe Armand
- Abraham Avigdor
- Robin Gasiorowski
- Yair Herishanu
- Colm Keane
- John Kuruvilla
- Rachel Marceau West
- Pallavi Pillai
- Rushdia Yusuf
- John Timmerman
View full abstract at Hemasphere…
P138: Updated Analysis of a Phase 1/2 Study Evaluating Pembrolizumab (pembro) Plus the Anti–Lymphocyte-Activation Gene 3 (LAG-3) Antibody Favezelimab for Heavily Pretreated Anti–PD-1–Refractory Classical Hodgkin Lymphoma (cHL)
Authors:
- John Timmerman
- David Lavie
- Nathalie A. Johnson
- Abraham Avigdor
- Peter Borchmann
- Charalambos Andreadis
- Ali Bazargan
- Gareth P. Gregory
- Colm Keane
- Inna Tzoran
- Vladan Vucinic
- Pier Luigi Zinzani
- Rachel Marceau West
- Pallavi Pillai
- Rushdia Yusuf
- Alex F. Herrera
View full abstract at Hemasphere…

ISHL13 Abstracts

Limited stages

T049: Factors driving treatment intensity in the whole cohort of patients with early-stage favorable (I-IIA), nonbulky Hodgkin Lymphoma enrolled in the RAFTING trial (NCT 04866654).

T050: Nodular lymphocyte predominant Hodgkin lymphoma in the Nordic countries – characteristics, treatment and survival

T051: Serum TARC Dynamics Correlate with Clinical Response and Metabolic Tumor Volume During Anti-PD1-Based First-Line HL Treatment in The GHSG Phase II NIVAHL Trial

P052: AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

P053: Development and validation of the Early stage (ES) classic Hodgkin Lymphoma (cHL) International Prognostication Index (E-HIPI): an individualized prediction model for progression-free survival (PFS) utilizing objective and continous variables

P054: Individualized Immunotherapy in Early-Stage Unfavorable Hodgkin Lymphoma - The Investigator-Initiated Phase II GHSG INDIE Trial (Trial in Progress)

P055: King Faisal Specialist Hospital and Research Centre

P056: Pediatric Infradiaphragmatic Hodgkin’s lymphoma: a unique identity

P057: Proton therapy for limited stage classical Hodgkin lymphoma patients (PRO-Hodgkin): an interim analysis of clinical outcome.

P058: Real-life data on morbidity and cause-specific mortality after combined modality treatment for classical Hodgkin lymphoma 2006-2015.

P059: Safe Radiotherapy for Pregnant Women with Hodgkin's Lymphoma: Myth or Reality?

P060: Total metabolic tumor volume impairs the successful detection of circulating tumor DNA (ctDNA) in early-stage Hodgin lymphoma patients – the preliminary report from the RAFTING trial.

P061: Variation in the delivery of radiotherapy as part of frontline curative treatment for Hodgkin lymphoma across healthcare providers in England

Pediatric and adolescent

T086: EFFICACY and TOLERABILITY in DECOPDAC21 versus COPDAC28 in PEDIATRIC INTERMEDIATE and ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA: INTERIM RESULTS of the EURONET-PHL-C2 RANDOMIZED STUDY

T087: Progression-Free Survival (PFS) with Nivolumab-AVD is superior to Brentuximab Vedotin-AVD with 2-year follow-up of S1826 in Adolescent Advanced Stage (AS) Classic Hodgkin Lymphoma (cHL)

T088: Updated Results from the Phase 2 KEYNOTE-667 Study: Pembrolizumab (pembro) in Children and Young Adults With Low-Risk Classical Hodgkin Lymphoma (cHL) and Slow Early Response (SER) to Front-Line Chemotherapy (chemo)

P089: An audit of compliance with recommendations for screening and management of Hodkins lymphoma in teenager and young adult population. Results from a baseline audit within the northern health and social care trust.

P090: Brentuximab-Associated Alopecia in Children and Young Adults with Newly Diagnosed Hodgkin Lymphoma

P091: Clinical study of immune-targeting combined with attenuated chemotherapy in the treatment of pediatric Hodgkin lymphoma

P092: CNS Involvement in Pediatric Hodgkin Lymphoma: A Retrospective Analysis of AHOD1331, EuroNet-PHL-C1 and EuroNet-PHL-C2 from SEARCH for CAYAHL

P093: Definition of independent lymph node regions in pediatric HL. An expert consensus by an International Collaboration on Staging Evaluation and Response Criteria Harmonization (SEARCH) for Children, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL)

P094: Dose-dense chemotherapy enables elimination of radiotherapy for a majority of patients with low-risk pediatric Hodgkin lymphoma: a report on HOD08 from the Pediatric Hodgkin Consortium

P095: Group-Based Trajectories of Health-related Quality of Life (HRQoL) among Patients with High-Risk Pediatric Hodgkin Lymphoma treated on the Children’s Oncology Group (COG) AHOD 1331 Study

P096: International Harmonization Efforts for Pediatric, Adolescent and Young Adult Hodgkin Lymphoma: A Current Report from the SEARCH FOR CAYAHL Group

P097: Is the EVA regimen (etoposide, vinblastine, doxorubicin) safe and effective for treating Hodgkin's lymphoma in pregnant patients?

P098: Omitting radiation in young adult females with Hodgkin’s disease, Is there an impact on outcome?

P099: PET/CT Response Assessment in Pediatric Hodgkin Lymphoma. Deauville Score 3 Does it really reflect Negativity?

P100: Prognostic Significance of PD1, PD-L1 Expression, Pathological Subtypes and Metabolic Activity on 18F-FDG PET/CT in Refractory/Relapsing Pediatric Hodgkin Lymphoma

P101: Towards Incorporation of Pediatric Specific Criteria in the Revised Lugano Classification of Hodgkin Lymphoma (HL) Staging and Response: Report from the ICML Pediatric Subcommittee

P102: Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma: A Sub-Study of Children’s Oncology Group AHOD0431

P103: Updated Results From the Phase 2 KEYNOTE-667 Study: Pembrolizumab (pembro) in Children and Young Adults With High-Risk Classical Hodgkin Lymphoma (cHL) With Slow Early Response (SER) to Front-Line Chemotherapy (chemo)

Biology and microenvironment

T025: Characterization of cancer-associated fibroblasts and their spatial architecture reveals heterogeneity and survival associations in classical Hodgkin lymphoma

T026: Circulating tumor DNA sequencing facilitates biological classification and individualized risk stratification in patients with Hodgkin lymphoma

T027: Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma

T028: Multi-Dimensional Profiling Unveils Distinct Molecular Subtypes in Classic Hodgkin Lymphoma

P029: A novel in vitro model to study the effect of PD1 inhibition in Hodgkin Lymphoma at a molecular level

P030: Cell-Free DNA as Potential Prognosticator and Tracking Tool in Classic Hodgkin Lymphoma: Molecular Profiling and Clinical Correlations.

P031: Characteristics and outcomes of patients with Hodgkins Lymphoma with Paraneoplastic manifestations

P032: CK2 FAVORS T-CELL CHEMOTAXIS THROUGHT THE RELEASE OF SOLUBLE FACTORS BY HODGKIN AND REED–STERNBERG CELLS

P033: Final analysis of correlation between serum TARC concentration and MTV,TLG in a cohort of Classical Hodgkin lymphoma during first line treatment.

P034: Gene Expression Signature Reveals a Protective Role of B-cells in the Progression of classical Hodgkin Lymphoma patients

P035: Histological Grading in Nodular Sclerosis Classical Hodgkin Lymphoma Identifies a Subgroup of Patients with Higher Early Response Rates and Better Prognosis in the Contemporary Treatment Era

P036: Immune landscape associated with response to brentuximab vedotin with ipilimumab and/or nivolumab in relapsed Hodgkin lymphoma in E4412 Phase 1

P037: Impact of Clonal hematopoiesis of indeterminate potential in classical Hodgkin lymphoma

P038: Molecular pathogenesis of Hodgkin lymphoma

P039: New understanding of oncogenic mechanisms in classical Hodgkin lymphoma

P040: Plasma proteins and Hodgkin's lymphoma: Proteome-wide Mendelian randomization and colocalization analyses

P041: Proteomic profile in classical Hodgkin Lymphoma patients with high inflammation

P042: Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity

P043: SPATIAL ORGANIZATION OF THE TUMOR MICROENVIRONMENT IN NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA AND T-CELL/HISTIOCYTE-RICH LARGE B-CELL LYMPHOMA: INSIGHTS FROM A PILOT COHORT STUDY

P044: Sulforaphane, a Natural Compound, Inhibits Cell Growth and Promotes NK Cell-Mediated Anti-Tumor Immune Responses Through cGAS-STING Pathway in Classical Hodgkin Lymphoma

P045: T-cell diversity and exclusion of blood-derived clonally expanded T-cells in the tumor microenvironment of classical Hodgkin Lymphoma

P046: Transcriptional reprogramming by mutated IRF4 in lymphoma

P047: Trial in Progress: Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma (NAHL)

P048: Tumor-associated macrophages correlate with skeletal involvement in classic Hodgkin lymphoma

Older patients

T074: A simplified frailty score predicts outcome in older patients with classical Hodgkin lymphoma treated with curative intent

T075: Characterisation of older Hodgkin Lymphoma patients using UK registry data from 1997-2023

T076: Feasibility and Efficacy of PET-guided BrECADD in Older Patients with Advanced-Stage classical Hodgkin Lymphoma: The Older Cohort of the International GHSG HD21 Trial

T077: Nivolumab-AVD improves 2-year progression-free and overall survival compared to Bv-AVD in older patients aged ≥60 years with advanced stage classical Hodgkin lymphoma (cHL) enrolled on SWOG S1826

P078: ‘ACOPP’ chemotherapy for older and less fit patients with Hodgkin lymphoma – a multicentre, retrospective study

P079: Anthracycline-based therapy for elderly HL patients : a retrospective series from a single South Italy center.

P080: Brentuximab vedotin monotherapy is a feasible and effective treatment in elderly and frail patients with classical Hodgkin lymphoma: Results of the prospective GHSG-NLG phase II BVB trial.

P081: Brentuximab vedotin, Cyclophosphamide, Doxorubicin and Prednisone (B-CAP) First-Line Treatment of Advanced-Stage Hodgkin Lymphoma: Final Results of the GHSG-NLG Phase II BVB Trial

P082: Elderly Classical Hodgkin Lymphoma: Croatian Cooperative Group for Hematological Diseases (KroHem) Experience

P083: Hodgkin Lymphoma in Older Patients (HoOP)- A European Retrospective Study

P084: Patients over the age of 60 years treated with Hodgkin's lymphoma at our Clinic

P085: Treatment Efficacy, Overall Survival, and Disease-Free Survival in Elderly versus Younger Patients with Hodgkin's Lymphoma: A Decade of Experience at a Latin American Reference Hospital

Advanced stages

T001: 2-Year Follow-up of the S1826 Study Confirms Improved Progression-Free Survival with Nivolumab-AVD Compared to Brentuximab Vedotin-AVD in Advanced Stage Classic Hodgkin Lymphoma

T002: Development and application of a validated MRD assay in Hodgkin Lymphoma

T003: EORTC-1537-COBRA: PHASE II STUDY OF VERY EARLY FDG-PET-RESPONSE ADAPTED TARGETED THERAPY FOR ADVANCED HODGKIN LYMPHOMA. PRIMARY ANALYSIS INCLUDING VALUE OF QUANTITATIVE PET ASSESSMENT AND TARC DYNAMICS

T004: Metabolic tumor volume after two cycles of chemotherapy in patients treated for advanced-stage Hodgkin Lymphoma: analysis of the German Hodgkin Study Group phase III HD18 and HD21 trials

P005: Accuracy of Ann Arbor Stage Assignment Based on PET/CT Reports Using a Large Language Model in Hodgkin Lymphoma Patients

P006: Adaptation of a PET-based treatment strategy and outcomes of patients with Advanced Hodgkins Lymphoma in resource constrained settings

P007: Are Four Cycles of BEACOPP Escalated Sufficient for Patients with Advanced Hodgkin Lymphoma and PET-2 Deauville Score 3?